Showing results (451-460 of 542) with videos related to
Sort By:
Pageof 55
Neurodegenerative Disease Management|June 13, 2024
Impact of a keto diet on symptoms of Parkinson's disease, biomarkers, depression, anxiety and quality of life: a longitudinal studyMelanie M Tidman, Dawn Reid White, Tim A WhiteNeurodegenerative Disease Management|February 1, 2019
Deutetrabenazine in the treatment of tardive dyskinesiaNicki Niemann, Joohi Jimenez-ShahedNeurodegenerative Disease Management|January 19, 2019
Tetrahydrocannabinol: cannabidiol oromucosal spray for treating symptoms of multiple sclerosis spasticity: newest evidenceTjalf ZiemssenNeurodegenerative Disease Management|October 22, 2020
Patient-reported impact of Charcot-Marie-Tooth disease: protocol for a real-world digital lifestyle studyFlorian P Thomas, Mario Saporta, Shahram Attarian, et al.Neurodegenerative Disease Management|October 5, 2020
Efficacy and safety of amantadine for the treatment of fatigue in multiple sclerosis: a systematic review and meta-analysisDominique Q Perez, Adrian I Espiritu, Roland Dominic G JamoraNeurodegenerative Disease Management|November 25, 2020
Living with secondary progressive multiple sclerosis in Europe: perspectives of multiple stakeholdersØivind Torkildsen, Ralf A Linker, Jose Mm Sesmero, et al.Neurodegenerative Disease Management|September 3, 2020
An international discrete choice experiment assessing patients' preferences for disease-modifying therapy attributes in multiple sclerosisBirgit Bauer, Bernd Brockmeier, Virginia Devonshire, et al.Neurodegenerative Disease Management|September 3, 2020
Application of the '5-2-1' screening criteria in advanced Parkinson's disease: interim analysis of DUOGLOBEJason Aldred, Marieta Anca-Herschkovitsch, Angelo Antonini, et al.Neurodegenerative Disease Management|November 11, 2020
Telehealth for the cognitively impaired older adult and their caregivers: lessons from a coordinated approachErica F Weiss, Rubina Malik, Teresa Santos, et al.Neurodegenerative Disease Management|November 11, 2020
Cognitive testing in the COVID-19 era: can existing screeners be adapted for telephone use?Andrew J LarnerPageof 55